PENELOPE B is a phase III international, multicentre, randomised, placebo-controlled, double-blind trial comparing the efficacy and safety of adding palbociclib to standard hormone therapy vs standard ...
What is the study about? HER2-RADiCAL is investigating whether some people with HER2 positive breast cancer can safely receive less treatment after surgery. HER2 is a protein which can cause cancer to ...
IMPORT HIGH is a phase III, prospective, randomised controlled trial to test whether dose escalated, intensity-modulated radiotherapy after conservation surgery for early breast cancer could reduce ...
Being overweight or obese is an important cause of rising cancer rates among younger adults in England, according to a major new study. Researchers at The Institute of Cancer Research, London, and ...
A blood test can predict how well patients with advanced breast cancer will respond to targeted therapies – before treatment begins, according to new research. A team from The Institute of Cancer ...
The Institute of Cancer Research, London, welcomes the decision by the National Institute for Health and Care Excellence (NICE) to recommend the targeted drug talazoparib (trade name Talzenna), in ...
Before I was diagnosed I was extremely well. I worked for Birmingham City Council and headed up training and employment services for people with disabilities. I absolutely loved my job. I worked very ...
A new immunotherapy drug has shown promise for safely treating prostate cancer, a phase I trial reports. Almost half of the patients in the trial that could be evaluated saw their tumour shrink after ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results